Free radicals are implicated in various chronic diseases. There has always been a search for new antioxidants. In this paper we have investigated Tamra bhasma, a metallic ayurvedic preparation. It is a time-tested medicine in Ayurveda and is in clinical use for various ailments specifically the free radical mediated diseases. Our results show that Tamra bhasma inhibits lipid peroxidation (LPO), prevents the rate of =erial oxidation of reduced glutathione (GSH) lion content and induces the activity of superoxide olsmutase (SOD) in rat liver homogenate in the bi-phasic manner. The drug was orally given for 7, 15 and 30 days in different doses. Best protective response was found at the dose of 0.Smg/100g body weight in albino rats, although it showed some histopathological changes at the dose of 20mg/100g body weight. The results suggest that this Ayurvedic preparation is not merely a source of copper metal, but it is a strong anti-oxidant with no detectable adverse effect in lower doses of therapeutic range.
INTRODUCTION
Free radicals are spontaneously produced in the mitochondria as a byproduct of electron transport chain. An enzyme called superoxide dismutase is responsible for its quick removal by its dismutation to hydrogen peroxide, which is finally hydrolyzed to water and oxygen with the help of catalase and glutathione peroxidase. In old age, the rate of production of free radical predominates than its removal, leading to peroxidation of all macromolecules including lipids, proteins and nucleic acids. Besides, many metabolic disorders such as diabetes, atherosclerosis, arthritis, nervous diseases etc are now established free radical mediated diseases.
The antioxidants are in use for the management of these diseases. Some of them are directly inactivating or quenching these free radicals like fat soluble vitamins, glutathione and various phytochemicals and others are responsible for the activation of endogenous antioxidant enzymes like selenium containing glutathione peroxidase and copper superoxide dismutase respectively. Copper is a trace element, involved as an essential constituent of certain enzymes such as catalase, tyrosinase, serum oxidase, ascorbic acid oxidase, cytochrome oxidase, etc (1) . Besides, copper is also important for the absorption of iron through the intestine. It is also reported forthe management of leucoderrna.
In the Ayurvedic description, several metallic preparations are in clinical use since 12 t~ century AD. They have specific methods for their detoxification and bhasma preparation, which becomes suitable for clinical use in therapeutic doses. Since these preparations are sustaining themselves since centuries in clinical use, therefore one can not exclude its use just by saying that heavy metals are toxic. Proper documentation is the demand of time to validate the claims about these metallic preparations. Copper is one such metal. In the Ayurvedic system of medicine, Tamra bhasma is recommended in the dose of 10 mg to 30 mg for an adult (70 kg body weight; 0.2mg/kg)to manage liver disorders, gastro-intestinal tract (GIT) disorders, old age diseases, leucoderma, cardiac problems (2) and vadous other free radical mediated disorders (3), either alone or as herbo-mineral compositions. Deficiency of copper in the body causes weight loss, bone disorders, microcytic hypochromic anaemia, hypopigmentation, graying of hair and demyelination of nerves etc (4).
We have earlier reported its in vitro response on lipid peroxidation (5) . Here, an in vivo study of Tamra bhasma has been made in albino rats on several free radical species and various toxicological parameters. The dose range was decided on the basis of human dose that is 10-30 mg/70 kg adult body weight. For toxicological study, dose was chosen on higher side with an objective to ascertain its safety margin.
MATERIALS AND METHODS

Chemicals-
Copper turnings (99.9% pure), thiobarbitudc acid, glacial acetic acid, EDTA, sodium dodecyl sulphate (SDS), hydrochloric acid (HCI), nitro blue tetrazolium (NBT), methionine, riboflavin, phosphotungstic acid (PTA) were purchased from Central Drug House (Pvt.) Ltd. Reduced glutathione and DTNB (5,5' Dithio-bis (2-nitrobenzoic acid) were procured from Sigma Chemical Co, St. Louis, MO, USA. Albino rats of inbred Charles Foster strain, (body weight between 100 to 150 g) were arranged from Central Animal House of our Institute.
Preparation of Tamra bhasma
Tamra bhasma was prepared by standard method described in the Ayurvedic classical text(2). Process of preparation was divided into 2 parts, Sodhan (purification) of raw copper and bhasma preparation. For purification, copper turnings were repeatedly heated to red hot condition and immediately quenched in different cold solvents in a sequence of Sessamum oil, butter milk, cow urine, sour gruel, decoction ofDolichos biflorus and juice of Oxalis orniculatum. This process was repeated for 5 times in each solvent. The end product of this process is claimed as sodhit copper (purified copper). It is brittle in nature and black in colour.
For the bhasma preparation, equal quantity of pudfied copper, purified sulphur (Shodhit gandhak) and pudfied mercury (Shodhffparad) were mixed. In the beginning, mercury and copper were titrated with lemon juice to make the amalgam. Then equal quantity of sulphurwas added to it and again titrated till black fine powder was formed. This powder was
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181-189 heated up to 700 o C for 9 hrs in a kupiyantra (glass bottle wrapped with seven layers of mud smeared cotton cloth) by gradual rise in temperature in a thermostatic controlled muffle furnace. Next day Tamra bhasma was collected from the bottom of the kupi and fine powder was made which passed 100% through 200 mesh sieves. This was tested for its quality as per classical methods (2). Bhasma was found floating on water surface. It did not change the colour of curd, when kept in contact for 24 hrs. It was not shining as the original metal, in the sunlight. It was further characterized by X ray defraction spectrum. It showed a peak of copper sulphide of intensity 27 and spacing value of 1.87. It also showed 4 extra peaks at different intensity and spacing value, which were not reported in the literature. The data was similar to what has been reported, previously by this laboratory (6) .
Determination of optimum dose
Animals were randomly selected and housed in plastic bottom cages. They were allowed free access to standard laboratory chow (Hindustan Lever, Mumbai) and water and kept on overnight fast before sacrifice. The Institute animal care and use committee approved the protocol of this study. To determine the LDso and optimum dose of Tamra bhasma in our experimental conditions, rats were divided in different groups (n=6) as sh0~wn in Table  1 . Animals of the first group received lml drug vehicle (20% gum acasia in distilled water) and served as sham control. The other group daily received Tamra bhasma suspension in different doses up to 30 days. The survival of each animal was monitored through out the experiment. At the end, blood was collected to assay the liver and kidney function in terms of serum GOT, GPT, alkaline phosphatase, lactate dehydrogenase, serum urea and serum creatinine. Finally the animals were sacrificed by cervical dislocation to collect liver and kidney for histological studies by using standard protocol(7). All the above estimations were carried out by using standard commercial kits.
Toxicological study
This study was divided into 3 phases (a) acute study for 3 days (b) sub-acute studies for 15 days and (c) chronic studies for 90 days. In these studies different doses ofTamra bhasma were orally given to rats as shown in Table 2 . In all the experiments hepatocellular enzymes namely SGOT, SGPT, alkaline phosphatase, LDH and two metabolites for the kidney function tests namely serum urea and serum creatinine were estimated. Histopathological changes in liver and kidney were carried out by using paraffin wax block and staining with hematoxylin and eosin. Inverse relation in the dose and duration of drug administration was maintained because in normal course of treatment, Tamra bhasma was given to the patients in very low dose and also for shorter duration.
Effect on antioxidant enzymes
Albino rats were divided into different groups (n = 6) as indicated in the respective tables. In the first group, which served as sham control, only drug vector (20% gum-acasia in water) was orally given in the dose of lml/100g body weight. In the treated groups, different concentrations of the Tamra bhasma were given for different duration that is 7, 10 and 30 days. Overnight fasted rats were anaesthetized by intra-peritonial injection of pentobarbitone (3mg/100g body weight). Liver was visualized, per/used with normal saline to make it blood free and dissected out. A small portion was fixed in 10% Bouin's solution for histopathological studies. Further 10% liver homogenate (0.8 -1.5 mg protein in 0.1 ml) was separately prepared in a glass-teflon homogenizer, for the estimation of TBARS and reduced glutathione (GSH). Protein concentration was measured by using standard method of Lowry etal (8) . To monitor the activity of superoxide dismutase, the homogenate was subjected to one step purification by differential centrifugation in a refngerated centrifuge at 12,000 rpm for 15 minutes. Rate of aerial oxidation of reduced glutathione was also estimated. For this, 3 ml of 10% liver homogenate was kept in a 35 mm petri dish and after every 10 minutes, 250 ml of the homogenate was taken out to estimate the concentration of reduced GSH (9).
Estimation of Thiobarbituric acid reactive substances (TBARS)
The degree of lipid peroxidation was assayed in terms of TBA reactive substances. Standard phosphotunegstic acid method (10) was used with slight modification (11) . In brief, 500ml of 10% liver homogenate was taken in a tube containing 0.5ml of 3% SDS, 0.2ml of 0.1 N HCI and 0.3ml of 10% PTA. It was mixed properly and then lml TBA (0.67% in 50% acetic acid) was added. It was mixed and heated for 30 minutes in a boiling water bath. The colour was extracted with 4ml butanol and Indian Journal of Clinical Biochemistry, 2003 absorbance was taken at 535 nm. The quantity of TBARS was expressed as nM/100mg protein.
Estimation of Glutathione (GSH)
Reduced GSH was estimated by using standard method of EIIman et al (9) . 250 ~.1 of incubation mixture was transferred to a tube containing 0.5 ml of precipitating buffer (5% TCA in 1 mM EDTA). The sample was centrifuged at 2000 g for 10 min and supernatant was collected. It was mixed with 2.5 ml of 0.1 M phosphate buffer (pH 8.0) and colour was developed by adding 0.01% of 100 ml DTNB (5,5 -Dithiobis (2~ acid). Absorbance was determined at 412 nm using Jasco spectrophotometer as described earlier (12) . The GSH values are expressed as mg/g of liver tissue.
Estimation of Superoxide dismutase (SOD)
The activity of SOD was assayed by the reduction of nitro blue tetrazolium (NB'r) to blue formazan (13) . Here the superoxides were produced by riboflavin mediated photochemical reaction system. In bdef, reaction mixture contained 1.7 ml of phosphate buffer (pH 7.8), 150 ml EDTA (10 mM), 600 ml methionine (130 raM), 300 ml NBT (750 mM), and different concentrations of drug. Reaction was initiated by adding 200 ml riboflavin (60 mM) and placing the tube in front of fluorescent light. A system, devoid of any superoxide-radical scavenger was used as a positive control to compare the results. Absorbance was taken at 560 nm at different time intervals as described earlier (14) . The activity of SOD are presented as units/rng protein.
RESULTS
Effect on survival
Different doses of Tamra bhasma were orally given to rats with an objective to determine the LDso. No death was noticed up to 30 clays at a dose of 480 mg per 100 g body weight (Table 1) .
Effect on liver and kidney functions
Oral administration of Tamra bhasma at a dose of 1000mg/kg body weight for 3 days did not show any change in the activity of serum GOT, GPT, alkaline phosphatase, lactate dehydrogenase, serum urea and serum creatinine. However in similar conditions, 100mg/kg body weight for 15 days showed slight increase in all these enzymes but a dose of 2mg/kg body wt. for 30 days and 5mg/kg body weight even for 90 days, did not show any change in these enzymes and metabolites. These doses were completely safe. Although there was slight increase in the serum urea in the dose of 100mg for 30 days treatment, but it was statistically insignificant. Interestingly in all the cases the survival was 100% (Table 2) .
Effect on histology of liver and kidney
There was no significant change up to the dose of 20mg/kg body weight, when given for 30 days. However on higher doses, necrosis and inflammation was noticed in kidney and liver (Table 3) . Results of 2mg/kg body weight for 30 days and 5 mg/kg body weight for 90 days were completely safe and did not show any change in the histological studies.
Effect on different antioxidant parameters
This experiment was carded out for 30 days by using different doses of Tamra bhasma through oral route. There was no increase in the level of lipid peroxidation as liver TBA-RS value was in the normal range, in the dose of 7.5 mg/kg body weight and below, but on higher doses there was dose dependent increase (Table 4) . Similarly on higher dose, there was rapid rate of aerial oxidation of GSH in the liver homogenate, but it was significantly maintained in the case of 5mg/kg dose. The initial value remained unchanged even up to 30 days treatment (Table 5 ). Interestingly the changes in the activity of superoxide dismutase was biphasic that is, on the doses below 5 mg/kg body weight, there was decrease in the activity of SOD, where as on higher doses it gradually increased (Table 6 ). This increase was also accompanied with that of the degree of lipid peroxidation and the rapid rate of GSH oxidation.
DISCUSSION
It is reported that, Tamra bhasma potentiates the antioxidant activity of animals, when given orally. The treated animals showed less degree of CHP induced lipid peroxidation(5). Interestingly there was no study on higher doses with reference to its toxicity and therapeutic efficacy in regards to its antioxidant property. Worldwide debate is on for the use the ayurvedic metallic preparations. Therefore this study becomes more relevant. Our results clearly indicated that Tamra bhasma does have antioxidant property in low doses, without any side effect, even up to 90 days of treatment in the dose of 5mg/kg body weight. However in higher doses, when given for a longer period, it induced lipid peroxidation, without any effect on the rate of survival (Table 1 ) but these tested doses are much higher than the human therapeutic doses. This data is consistent with the literature report, where its use for longer duration at a time is contraindicated (15) . The hepatocellular enzymes in serum also showed no significant rise in their activity when given for 90 days in a low dose of 5mg/kg body weight. However 100mg/kg body weight dose for 15 days did show slight adverse effect. Regarding the protection of reduced glutathione, it was found that Tamra bhasma enhances the initial value of GSH in all the animals of drug treated group. In lower doses (5 mg/kg body weight and below) it protects GSH against the aerial oxidation but on higher doses it has no protective response. In the case of superoxide dismutase a biphasic response was observed. In the lower doses (5mg/kg body weight) the SOD activity in the liver homogenate was lower but on higher doses the activity was enhanced. This could be because SOD has a property of substrate induced induction. In lower doses it is not producing any kind of superoxide therefore the SOD activity remains in the normal range but at higher doses, the bhasma might be generating this radical as a si(:jLe effect, which may be the root cause of enhanced SOD activity. This adverse effect in higherdoses is also supported by the enhanced lipid peroxidation. Taking all the observations into consideration, it could be concluded that Tamra bhasma potentiates the antioxidant activity of an animal, when given in lower doses. The myth of toxicity of these preparations in the therapeutic doses should be ruled out because it has not shown any change in the histology of liver and kidney. The SGOT and SGPT, alkaline phosphatase and LDH have also not changed. Further various claims of Tamra bhasma, mentioned in Ayurveda could be explained by its antioxidant property.
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